Company & Sponsor Intelligence
Neuromed IRCCS
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting2
Completed1
Countries1
Therapeutic footprint
alzheimersepilepsymigraine_headachemultiple_sclerosisparkinsons
Indexed studies
NCT07533084Italian Validation of the dNA Scale and Its Correlation With Neurocognitive Variables
alzheimers · ItalyNOT_YET_RECRUITING
alzheimers · ItalyNOT_YET_RECRUITING
NCT03998787Metabotropic Receptors For Glutamate Type 3 In Parkinson's
parkinsons · UNKNOWN
parkinsons · UNKNOWN
NCT03999788miR-142-3p as Potential Biomarker of Synaptopathy in MS
multiple_sclerosis · ItalyNA
multiple_sclerosis · ItalyNA
NCT05811013Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis
multiple_sclerosis · ItalyNA
multiple_sclerosis · ItalyNA
NCT04647825NEED: Neuromed Epilepsy EEG Database. A Large EEG Database of Epilepsy Patients for Research Community.
epilepsy · ItalyUNKNOWN
epilepsy · ItalyUNKNOWN
NCT06640634Effect of Anodal Transcranial Direct Current Stimulation on Postdural Puncture Headache
migraine_headache · ItalyNA
migraine_headache · ItalyNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →